sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
SCTX
Updated 10/6/2026, 9:41 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| SCTX Scribe Therapeutics, Inc. | Buy | $4,999,995 | AH Bio Fund II, L.P. 10% owner and 5 others | 333,333 sh | at $15.00 | Filed Jul 29, 7:09 PM ET | Filing | |
| SCTX Scribe Therapeutics, Inc. | Buy | $15,000,000 | GORDON CARL L Director | 1,000,000 sh | at $15.00 | Filed Jul 29, 6:50 PM ET | Filing | |
| SCTX Scribe Therapeutics, Inc. | Buy | $15,000,000 | ORBIMED ADVISORS LLC Director and 1 other | 1,000,000 sh | at $15.00 | Filed Jul 29, 6:47 PM ET | Filing | |
| SCTX Scribe Therapeutics, Inc. | Buy | $36,259,761 | Aghazadeh Behzad Director, 10% owner and 2 others | 2,391,238 sh | at $15.16 | Filed Jul 28, 9:30 PM ET | Filing | |
| SCTX Scribe Therapeutics, Inc. | Buy | $45,000 | Lucas Svetlana Chief Business Officer | 3,000 sh | at $15.00 | Filed Jul 27, 9:42 PM ET | Filing | |
| SCTX Scribe Therapeutics, Inc. | Buy | $39,990 | Parrot David Chief Financial Officer | 2,666 sh | at $15.00 | Filed Jul 27, 9:20 PM ET | Filing |